-
T595109-500mgE3 ligase ligand-linker conjugate, Thalidomide-O-amido-PEG4-azide, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595113-100mgE3 ligase ligand-linker conjugate, Thalidomide-O-amido-PEG4-propargyl, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595113-250mgE3 ligase ligand-linker conjugate, Thalidomide-O-amido-PEG4-propargyl, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595113-500mgE3 ligase ligand-linker conjugate, Thalidomide-O-amido-PEG4-propargyl, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595102-100mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Acid, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595102-250mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Acid, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595102-500mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Acid, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595106-100mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Amine, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595106-250mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Amine, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T595106-500mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Amine, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T597237-100mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Azide, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
T597237-250mgE3 ligase ligand-linker conjugate, Thalidomide-O-PEG4-Azide, is synthesized compound that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.